Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$5.5M |
 |
Gilead SciencesGILD |
-$4.04B |
 |
AmgenAMGN |
-$189M |
 |
Editas MedicineEDIT |
-$7M |
 |
Crispr TherapeuticsCRSP |
-$171M |
Are Creative Medical Tech Insiders Buying or Selling?
Creative Medical Tech (CELZ) has had no reported insider transactions in the past 90 days. The most recent was Michael Finger, who sold 750 shares at $5.75 on February 19, 2025.
Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the CELZ AI Score. For government officials trading this stock, see CELZ congressional trading.
Recent Creative Medical Tech Insider Transactions
| Insider | Transaction Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael Finger | Feb 19, 2025 | Sell | 750 | $5.75 | $4,300 |
Frequently Asked Questions: Creative Medical Tech Insider Trading
Creative Medical Tech insiders have not reported any transactions in the past 90 days.
The most recent sale was by Michael Finger who sold 750 shares on February 19, 2025. View all transactions in the table on this page.
Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.
Finger Michael H. has sold the most CELZ stock in the last 2 years, with a total value of $4,300.
The total value of insider transactions for Creative Medical Tech in the last 2 years is negative, amounting to -$4,300. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
